NCT06810167View on ClinicalTrials.gov

Assessing Tenapanor as a Treatment of CF-related Constipation.

PHASE3RecruitingINTERVENTIONAL

Enrollment

25

Participants

Timeline

Start Date

June 1, 2025

Primary Completion Date

February 1, 2026

Study Completion Date

June 30, 2027

Conditions

Cystic FibrosisConstipation

Interventions

DRUG

Tenapanor

CF patients with CFrC will ingest one 50 mg tablet of tenapanor twice daily for 4 weeks.

Trial Locations (1)

02114

RECRUITING

Massachusetts General Hospital, Boston

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Ardelyx

INDUSTRY

lead

Massachusetts General Hospital

OTHER